PFG
AMGN icon

Piershale Financial Group’s Amgen AMGN Stock Holding History

Piershale Financial Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-22,645
Closed -$2.79M – 170
2014
Q1 		$2.79M Sell
22,645
-5,520
-20% -$669K 3.26% 9
2013
Q4 		$3.21M Buy
+28,165
New +$3.2M 4.66% 8

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Piershale Financial Group's AMGN Position: Q2 2014 in Review

Piershale Financial Group sold out of Amgen (AMGN) in Q2 2014, closing a stake of 22,645 shares — an estimated $2.79M sold.

Piershale Financial Group first reported a position in AMGN in Q4 2013 and held it in 2 quarters. The position peaked at $3.21M in Q4 2013. 1,185 funds tracked by Wall St. Rank hold AMGN as of Q2 2014.

  • Piershale Financial Group reported no remaining Amgen position as of Q2 2014 after selling out during the quarter.
  • Piershale Financial Group sold 22,645 Amgen shares in Q2 2014, an estimated $2.79M.
  • Piershale Financial Group first reported a position in Amgen in Q4 2013 and held it in 2 quarters.
  • Piershale Financial Group's Amgen position peaked at $3.21M in Q4 2013.
  • 1,185 funds tracked by Wall St. Rank held Amgen as of Q2 2014.

Based on Piershale Financial Group's 13F filing for Q2 2014, filed 17 Jul 2014.